SUSTAINED RELEASE CYCLOSPORINE THERAPY FOR BILATERAL KERATOCONJUNCTIVITIS SICCA IN A RED WOLF (CANIS RUFUS)

Anne E. Acton; A. Brady Beale; Brian C. Gilger; Michael K. Stoskopf

doi:10.1638/06-021.1

We can help you reset your password using the email address linked to your BioOne Complete account.

Registered users receive a variety of benefits including the ability to customize email alerts, create favorite journals list, and save searches. Please note that a BioOne web account does not automatically grant access to full-text content. An institutional or society member subscription is required to view non-Open Access content. Contact helpdesk@bioone.org with any questions.

All Fields are Required

First Name

Last/Family Name

Password

Password Requirements: Minimum 8 characters, must include as least one uppercase, one lowercase letter, and one number or permitted symbol Valid Symbols for password:
~ Tilde
! Exclamation Mark
@ At sign
$ Dollar sign
^ Caret
( Opening Parenthesis
) Closing Parenthesis
_ Underscore
. Period

Confirm Password

Web Account created successfully

Anne E. Acton, A. Brady Beale, Brian C. Gilger, Michael K. Stoskopf

Abstract

A 12-yr-old intact male red wolf (Canis rufus) diagnosed with bilateral idiopathic dry eye was treated with subconjunctival drug delivery implants designed to release therapeutic levels of cyclosporine from 12–24 mo. Normal tear production and corneal health has been maintained, alleviating the need for daily handling of the animal for topical medication.

Citation Download Citation

Anne E. Acton, A. Brady Beale, Brian C. Gilger, and Michael K. Stoskopf "SUSTAINED RELEASE CYCLOSPORINE THERAPY FOR BILATERAL KERATOCONJUNCTIVITIS SICCA IN A RED WOLF (CANIS RUFUS)," Journal of Zoo and Wildlife Medicine 37(4), 562-564, (1 December 2006). https://doi.org/10.1638/06-021.1

Received: 18 March 2006; Published: 1 December 2006

You currently do not have any folders to save your paper to! Create a new folder below.